These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38036858)

  • 1. Rewiring the future: drugs abused in adolescence may predispose to mental illness in adult life by altering dopamine axon growth.
    Avramescu RG; Hernandez G; Flores C
    J Neural Transm (Vienna); 2024 May; 131(5):461-467. PubMed ID: 38036858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCC Receptors Drive Prefrontal Cortex Maturation by Determining Dopamine Axon Targeting in Adolescence.
    Reynolds LM; Pokinko M; Torres-Berrío A; Cuesta S; Lambert LC; Del Cid Pellitero E; Wodzinski M; Manitt C; Krimpenfort P; Kolb B; Flores C
    Biol Psychiatry; 2018 Jan; 83(2):181-192. PubMed ID: 28720317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine Development in the Mouse Orbital Prefrontal Cortex Is Protracted and Sensitive to Amphetamine in Adolescence.
    Hoops D; Reynolds LM; Restrepo-Lozano JM; Flores C
    eNeuro; 2018; 5(1):. PubMed ID: 29333488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique effects of social defeat stress in adolescent male mice on the Netrin-1/DCC pathway, prefrontal cortex dopamine and cognition (Social stress in adolescent vs. adult male mice).
    Vassilev P; Pantoja-Urban AH; Giroux M; Nouel D; Hernandez G; Orsini T; Flores C
    eNeuro; 2021 Feb; 8(2):. PubMed ID: 33619036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine Axon Targeting in the Nucleus Accumbens in Adolescence Requires Netrin-1.
    Cuesta S; Nouel D; Reynolds LM; Morgunova A; Torres-Berrío A; White A; Hernandez G; Cooper HM; Flores C
    Front Cell Dev Biol; 2020; 8():487. PubMed ID: 32714924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of dopamine and glutamate co-release in the nucleus accumbens in mediating the actions of drugs of abuse.
    Buck SA; Torregrossa MM; Logan RW; Freyberg Z
    FEBS J; 2021 Mar; 288(5):1462-1474. PubMed ID: 32702182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphetamine in adolescence disrupts the development of medial prefrontal cortex dopamine connectivity in a DCC-dependent manner.
    Reynolds LM; Makowski CS; Yogendran SV; Kiessling S; Cermakian N; Flores C
    Neuropsychopharmacology; 2015 Mar; 40(5):1101-12. PubMed ID: 25336209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights to drug addiction derived from ultrastructural views of the mesocorticolimbic system.
    Morales M; Pickel VM
    Ann N Y Acad Sci; 2012 Feb; 1248():71-88. PubMed ID: 22171551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Adolescence is a Critical Period for the Maturation of Inhibitory Behavior.
    Reynolds LM; Yetnikoff L; Pokinko M; Wodzinski M; Epelbaum JG; Lambert LC; Cossette MP; Arvanitogiannis A; Flores C
    Cereb Cortex; 2019 Aug; 29(9):3676-3686. PubMed ID: 30295713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicological effects of propofol abuse on the dopaminergic neurons in ventral tegmental area and corpus striatum and its potential mechanisms.
    Chen Q; Li S; Han Y; Wei X; Du J; Wang X; Su B; Li J
    J Toxicol Sci; 2020; 45(7):391-399. PubMed ID: 32612007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making Dopamine Connections in Adolescence.
    Hoops D; Flores C
    Trends Neurosci; 2017 Dec; 40(12):709-719. PubMed ID: 29032842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood.
    Nemoda Z; Szekely A; Sasvari-Szekely M
    Neurosci Biobehav Rev; 2011 Aug; 35(8):1665-86. PubMed ID: 21527290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptic structure and connectivity of serotonin terminals in the ventral tegmental area: potential sites for modulation of mesolimbic dopamine neurons.
    Van Bockstaele EJ; Cestari DM; Pickel VM
    Brain Res; 1994 Jun; 647(2):307-22. PubMed ID: 7522922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescence versus adulthood: Differences in basal mesolimbic and nigrostriatal dopamine transmission and response to drugs of abuse.
    Corongiu S; Dessì C; Cadoni C
    Addict Biol; 2020 Jan; 25(1):e12721. PubMed ID: 30779271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV Infection and Neurocognitive Disorders in the Context of Chronic Drug Abuse: Evidence for Divergent Findings Dependent upon Prior Drug History.
    Illenberger JM; Harrod SB; Mactutus CF; McLaurin KA; Kallianpur A; Booze RM
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):715-728. PubMed ID: 32533296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunctional mesocortical dopamine circuit at pre-adolescence is associated to aggressive behavior in MAO-A hypomorphic mice exposed to early life stress.
    Frau R; Fanni S; Serra V; Simola N; Godar SC; Traccis F; Devoto P; Bortolato M; Melis M
    Neuropharmacology; 2019 Nov; 159():107517. PubMed ID: 30738037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DCC-related developmental effects of abused- versus therapeutic-like amphetamine doses in adolescence.
    Cuesta S; Restrepo-Lozano JM; Popescu C; He S; Reynolds LM; Israel S; Hernandez G; Rais R; Slusher BS; Flores C
    Addict Biol; 2020 Jul; 25(4):e12791. PubMed ID: 31192517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. unc5c haploinsufficient phenotype: striking similarities with the dcc haploinsufficiency model.
    Auger ML; Schmidt ER; Manitt C; Dal-Bo G; Pasterkamp RJ; Flores C
    Eur J Neurosci; 2013 Sep; 38(6):2853-63. PubMed ID: 23738838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine and the diseased brain.
    Kienast T; Heinz A
    CNS Neurol Disord Drug Targets; 2006 Feb; 5(1):109-31. PubMed ID: 16613557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 25B-NBOMe, a novel N-2-methoxybenzyl-phenethylamine (NBOMe) derivative, may induce rewarding and reinforcing effects via a dopaminergic mechanism: Evidence of abuse potential.
    Custodio RJP; Sayson LV; Botanas CJ; Abiero A; You KY; Kim M; Lee HJ; Yoo SY; Lee KW; Lee YS; Seo JW; Ryu IS; Kim HJ; Cheong JH
    Addict Biol; 2020 Nov; 25(6):e12850. PubMed ID: 31749223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.